Results 191 to 200 of about 3,530 (206)
Some of the next articles are maybe not open access.

Lentinan

Clinical Immunotherapeutics, 1994
Manabu Suzuki   +4 more
openaire   +1 more source

[Results of phase III study of lentinan].

Gan to kagaku ryoho. Cancer & chemotherapy, 1985
A follow-up survey of survivals (Oct. 1 '80 to May 1, '84) in a randomized controlled study (Aug. '79 to Sept. 30' 80) of lentinan in combination administration with chemotherapeutic agents such as 5FU + mitomycin C or tegafur on patients with advanced or recurrent gastrointestinal cancer has shown that lentinan has been effective in such cases with ...
T, Taguchi   +6 more
openaire   +1 more source

Lentinan as a distinct immunopotentiator

International Journal of Immunopharmacology, 1980
J. Hamuro   +5 more
openaire   +1 more source

[Anticancer immunotherapy with perorally effective lentinan].

Gan to kagaku ryoho. Cancer & chemotherapy, 2005
Lentinan is a beta(1-3) glucan clarified to have a life prolonging effect in non-operable, recurrent gastric cancer patients in combination with chemotherapy. The long lasting issue remaining to be resolved has been the ineffectiveness of Lentinan when administered per-orally.
openaire   +1 more source

Lentinan

Drugs of the Future, 1981
openaire   +1 more source

Immunomodulating and antitumor activity of lentinan

International Journal of Immunopharmacology, 1982
Frederick C. Reed   +2 more
openaire   +1 more source

Lentinan

2006
openaire   +1 more source

Lentinan

2016
openaire   +1 more source

Antitumor Polysaccharide Lentinan—A T Cell Adjuvant2

JNCI: Journal of the National Cancer Institute, 1973
Gunther Dennert, Derek Tucker
openaire   +1 more source

Home - About - Disclaimer - Privacy